Compare Organon & Co. Common Stock (OGN) vs Principal Financial Group Inc Common Stock (PFG) Price & Performance

Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.

OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.

Principal Financial Group (PFG) trades at $107.64, down 0.19% with a bearish technical outlook. The stock shows mixed fundamentals with recent earnings beats but faces valuation concerns at a P/E of 15.33. Recent acquisition of Beam Benefits aims to expand digital capabilities in specialty benefits, while analyst sentiment remains cautious with a 'Hold' consensus rating and $108.33 price target.

PFG presents a balanced risk-reward profile with steady revenue growth and improving profit margins, but faces headwinds from technical weakness and mixed analyst sentiment. The Beam Benefits acquisition provides growth potential in the SMB market, though execution risks and competitive pressures in the multiline insurance sector warrant monitoring for investors seeking exposure to financial services.